BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37352473)

  • 1. New directions in psychiatric drug development: promising therapeutics in the pipeline.
    Brady LS; Lisanby SH; Gordon JA
    Expert Opin Drug Discov; 2023; 18(8):835-850. PubMed ID: 37352473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence in early drug discovery enabling precision medicine.
    Boniolo F; Dorigatti E; Ohnmacht AJ; Saur D; Schubert B; Menden MP
    Expert Opin Drug Discov; 2021 Sep; 16(9):991-1007. PubMed ID: 34075855
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of response to drug therapy in psychiatric disorders.
    Stern S; Linker S; Vadodaria KC; Marchetto MC; Gage FH
    Open Biol; 2018 May; 8(5):. PubMed ID: 29794033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redirecting the revolution: new developments in drug development for psychiatry.
    Brady LS; Potter WZ; Gordon JA
    Expert Opin Drug Discov; 2019 Dec; 14(12):1213-1219. PubMed ID: 31545131
    [No Abstract]   [Full Text] [Related]  

  • 5. Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches.
    Lin E; Lin CH; Lane HY
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision medicine for suicidality: from universality to subtypes and personalization.
    Niculescu AB; Le-Niculescu H; Levey DF; Phalen PL; Dainton HL; Roseberry K; Niculescu EM; Niezer JO; Williams A; Graham DL; Jones TJ; Venugopal V; Ballew A; Yard M; Gelbart T; Kurian SM; Shekhar A; Schork NJ; Sandusky GE; Salomon DR
    Mol Psychiatry; 2017 Sep; 22(9):1250-1273. PubMed ID: 28809398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational precision medicine: an industry perspective.
    Hartl D; de Luca V; Kostikova A; Laramie J; Kennedy S; Ferrero E; Siegel R; Fink M; Ahmed S; Millholland J; Schuhmacher A; Hinder M; Piali L; Roth A
    J Transl Med; 2021 Jun; 19(1):245. PubMed ID: 34090480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs.
    Le-Niculescu H; Roseberry K; Gill SS; Levey DF; Phalen PL; Mullen J; Williams A; Bhairo S; Voegtline T; Davis H; Shekhar A; Kurian SM; Niculescu AB
    Mol Psychiatry; 2021 Jul; 26(7):2776-2804. PubMed ID: 33828235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomic Biomarkers and Their Applications in Psychiatry.
    Kam H; Jeong H
    Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33266292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIMH initiatives to facilitate collaborations among industry, academia, and government for the discovery and clinical testing of novel models and drugs for psychiatric disorders.
    Brady LS; Winsky L; Goodman W; Oliveri ME; Stover E
    Neuropsychopharmacology; 2009 Jan; 34(1):229-43. PubMed ID: 18800066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics Biomarkers for Precision Psychiatry.
    Shih PB
    Adv Exp Med Biol; 2019; 1161():101-113. PubMed ID: 31562625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public-private partnerships to revitalize psychiatric drug discovery.
    Brady LS; Potter WZ
    Expert Opin Drug Discov; 2014 Jan; 9(1):1-8. PubMed ID: 24308355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New and emerging approaches to treat psychiatric disorders.
    Scangos KW; State MW; Miller AH; Baker JT; Williams LM
    Nat Med; 2023 Feb; 29(2):317-333. PubMed ID: 36797480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review on Deep Learning-driven Drug Discovery: Strategies, Tools and Applications.
    Sumathi S; Suganya K; Swathi K; Sudha B; Poornima A; Varghese CA; Aswathy R
    Curr Pharm Des; 2023 May; 29(13):1013-1025. PubMed ID: 37055908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics.
    Carreon RL; Rivas-Grajales AM; Murphy N; Mathew SJ; Jha MK
    Adv Neurobiol; 2023; 30():287-297. PubMed ID: 36928855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Psychiatry: Biomarker-Guided Tailored Therapy for Effective Treatment and Prevention in Major Depression.
    Jones C; Nemeroff CB
    Adv Exp Med Biol; 2021; 1305():535-563. PubMed ID: 33834417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial Intelligence in Psychiatry.
    Fakhoury M
    Adv Exp Med Biol; 2019; 1192():119-125. PubMed ID: 31705492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine Learning in Neural Networks.
    Lin E; Tsai SJ
    Adv Exp Med Biol; 2019; 1192():127-137. PubMed ID: 31705493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.